SPONSOR

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 2, Phase 3, Phase 1

Conditions studied: Trastuzumab-rezetecan HER2-low Breast Cancer HER2-positive Breast Cancer Lung Cancer Breast Cancer Colorectal Cancer Stomach Cancer Liver Cancer Hepatocellular Carcinoma Non-resectable Thrombocytopenia

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Trastuzumab-rezetecan, HER2-low Breast Cancer, HER2-positive Breast Cancer, Lung Cancer.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

How many clinical trials has Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University sponsored?

ClinicalMetric currently tracks 21 clinical trials sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, of which 21 are actively recruiting participants. These trials cover conditions including Trastuzumab-rezetecan, HER2-low Breast Cancer, HER2-positive Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University research focus on?

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University clinical trials span Trastuzumab-rezetecan, HER2-low Breast Cancer, HER2-positive Breast Cancer, Lung Cancer, Breast Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University clinical trial?

To participate in a Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials with current recruitment status updated daily.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Frequently Asked Questions — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Clinical Trials by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer

Large Language Models Assist in Tumor MDT

mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria

Herombopag Treated T-DM1 Induced Platelet Reduction

Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC

Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

Deep Learning-based sbORN Diagnostic Model

Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab

Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL

Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial

OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)

Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis